Relatlimab
Relatlimab (BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM) . Relatlimab is often used with Nivoluma to treat advanced melanoma.
Product Specifications
CAS Number
1673516-98-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MT-CASTER-C 1 Unit
Contains: 1 x MT-G01; 1 x MT-T01; 2 x MT-02; 1 x MJ-C01 and 1 x MT-C03
Ask
View Details MBS1409389-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Uncharacterized protein P11E10.01 (SPAP11E10.01)
Ask
View Details MBS1409389-02 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe Uncharacterized protein P11E10.01 (SPAP11E10.01)
Ask
View Details